REGULATION OF MACROPHAGE ACTIVATION MARKERS BY IL-4 AND IFN-GAMMA IS SUBPOPULATION-SPECIFIC

被引:15
作者
MOLINA, IJ [1 ]
HUBER, BT [1 ]
机构
[1] TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111
关键词
D O I
10.1016/0008-8749(91)90347-E
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have addressed the differential regulatory properties that IFN-γ and IL-4 exert on macrophage (Mφ) subpopulations. For this purpose, Thyoglicolate-, Peptone-, and Con A-elicited Mφ, as well as bone marrow-derived Mφ and P388D1 cells, were cultured in the presence of either IFN-γ or IL-4. The expression of LFA-I, Mac-1, and Mac-2 after this treatment was studied by FACS analysis. We have found that these surface molecules are differentially modulated by the two lymphokines, depending on the Mφ subpopulation studied. Mac- I is upregulated only in Thyoglicolate-elicited cells after treatment with IFN-γ, while no change in the expression of Mac-2 was observed in any of the groups. LFA-I is upregulated by IFN-γ in Thyoglicolate- and bone marrow-derived Mφ and P388D1 cells, while IL-4 does not induce LFA-1 on these cells. Interestingly, however, we have observed the reverse situation on Con A-elicited Mφ, where a strong induction of LFA-1 is achieved by treatment of the cells with IL-4, while IFN-γ does not modify the expression of this antigen. Our results obtained with the lymphokine-stimulated Mφ are interpreted in the context of functionally induced Mφ subpopulations, which might be regulated by either Th1 or Th2 CD4+ T cells. Thyoglicolate-elicited Mφ may represent the in vitro equivalent of a Mφ subpopulation regulated in vivo by Th1 cells while Con A-elicited Mφ could be the equivalent of a subpopulation regulated by Th2 cells. © 1991.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 20 条
[1]  
BELLER DI, 1982, J IMMUNOL, V129, P971
[2]   DNA METHYLATION AND GENE ACTIVITY [J].
CEDAR, H .
CELL, 1988, 53 (01) :3-4
[3]   THE MAC-2 ANTIGEN IS A GALACTOSE-SPECIFIC LECTIN THAT BINDS IGE [J].
CHERAYIL, BJ ;
WEINER, SJ ;
PILLAI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :1959-1972
[4]  
COWING C, 1979, J IMMUNOL, V120, P378
[5]  
CRAWFORD RM, 1987, J IMMUNOL, V139, P135
[6]  
GAJEWSKI TF, 1990, J IMMUNOL, V144, P4110
[7]  
HAMILTON TA, 1981, J IMMUNOL, V127, P1702
[8]  
HO MK, 1982, J IMMUNOL, V128, P1221
[9]  
KURZINGER K, 1981, J IMMUNOL, V127, P596
[10]  
MOLINA IJ, 1989, J IMMUNOL, V143, P39